Loading...
•
Jun 30, 2023
ResMed Q4 2023 Earnings Report
ResMed's Q4 2023 earnings showcased strong double-digit growth, driven by increased demand for sleep and respiratory care devices and software solutions.
Key Takeaways
ResMed Inc. reported a 23% increase in revenue to $1.1 billion for the fourth quarter of fiscal year 2023. Diluted earnings per share were $1.56, and non-GAAP diluted earnings per share were $1.60. The company's performance was driven by strong global demand for its cloud-connected flow generator devices, patient interfaces, and software solutions.
Revenue increased by 23% to $1.1 billion, reflecting strong growth in constant currency.
Diluted earnings per share (EPS) reached $1.56, while non-GAAP diluted EPS was $1.60.
Operating cash flow was $237.4 million for the quarter.
The company's software-as-a-service revenue increased by 34%.
ResMed
ResMed
ResMed Revenue by Geographic Location
Revenue by Geographic Location
U.S., Canada, and Latin America Revenue
CapyFin.comEurope, Asia, and other markets Revenue
CapyFin.com Forward Guidance
ResMed is focused on delivering therapy and digital health solutions to improve people's lives outside the hospital, aiming to help 250 million lives in 2025.
Revenue & Expenses
Visualization of income flow from segment revenue to net income